L’Oréal recalling acne creams sold at Walmart, Target, and Walgreens due to ‘cancer-causing chemical’
Makeup company L’Oréal has recalled popular brand La Roche-Posay’s acne cream because it may contain benzene, a cancer-causing chemical, according to New York Post. Effaclar Duo Dual-Action Acne Treatment contains benzoyl peroxide, which could have the known carcinogen, according to Valisure, an independent testing lab in Connecticut.
Beauty care company issues recall for facial treatment due to cancer-causing chemical
One of the biggest beauty brands issued a voluntary recall for a facial treatment due to concerns that it may contain a cancer-causing chemical.
L'Oreal Issues Recall Over Cancer-Linked Chemical in Acne Cream
Benzene is a well-documented carcinogen that has been linked to leukemia and other blood disorders with prolonged exposure, according to the American Cancer Society (American Cancer Society). The chemical is found in crude oil, gasoline and tobacco smoke and is also used in industrial manufacturing.
Hugely popular face cream is urgently recalled in US over contamination with chemical linked to cancer
A HUGELY popular beauty item has been urgently recalled over fears they could contain cancer-causing chemicals. L’Oréal has slapped a ‘do not use’ alert on its La Roche Posay
L’Oreal Recalls Popular La Roche-Posay Acne Treatment Over Cancer-Causing Chemical
Posay’s Effaclar Duo acne treatment due to concerns over benzene contamination, a known carcinogen.Benzoyl peroxide, a key ingredient in Effaclar Duo, can degrade into benzene under certain conditions,
Acne product from popular skin care brand recalled due to potential cancer-causing chemical
The chemical that caused the recall is found in gasoline and tobacco; large amounts of the chemical can cause leukemia.
Popular makeup brand recalls acne treatment for possible cancer-causing ingredient
Makeup company L’Oréal S.A. has issued a recall on its popular acne cream Effaclar Duo due to concern that benzene, a known carcinogen, is in the product. Last year, independent Connecticut testing lab Valisure,
Cancer-causing chemical leads popular company to recall skin product
The recall comes in the wake of concerns over contamination of benzene, news outlet reported. A spokesperson for La Roche-Posay wrote in a statement to cleveland.com and The Plain Dealer that product safety is the company’s highest priority.
L’Oréal Act for Dermatology Aims to Democratize Skin Health Access
The 20 million euro, five-year program is to help support the 2.1 billion people worldwide living with skin disease.
Meet world's five richest women: From L'Oréal to Amazon, which companies are they associated with?
They own billions of dollars but are also known for making strides in the fields of business and philanthropy. They are ...
Cosmetics Business2d
L’Oréal’s dermatology arm launches €20 million skin health programme
L’Oréal Groupe has launched L’Oréal Act for Dermatology, a five-year skin health programme, under its Dermatological Beauty ...
L’Oréal USA Sells Carol’s Daughter to Independent Entrepreneur
After a decade under its ownership, L’Oréal USA has sold Carol’s Daughter to an unnamed independent beauty entrepreneur. The ...
CNA12h
CNA938 Rewind - Empowering SG Women in Science with the L'Oréal Foundation and UNESCO
In ‘Made in SG’, Melanie Oliveiro speaks with two local scientists who were celebrated at the L’Oréal-UNESCO For Women in Science programme. Assistant Professor Iris Yu from NUS will discuss how she p ...
Beauty Packaging1d
L’Oréal Reinforces Leadership and Commitment to Cosmetic Safety
Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our ...
Inside L’Oréal’s Biggest Bet Yet on Innovation
“We are opening a new era and chapter of innovation,” said Barbara Lavernos, deputy CEO of L’Oréal, in an exclusive interview ...
L'Oreal CEO plays down the impact of U.S. tariffs, says he's 'not overly concerned'
L'Oreal CEO Nicolas Hieronimus said he is "not overly concerned" over the impact of White House tariffs on the company.